Lantern Pharma to Report First Quarter 2026 Operating & Financial Results on May 15th, 2026
Go back to Lantern Pharma to Report First Quarter 2026 Operating & Financial Results on May 15th, 2026| (NASDAQ: LTRN) | Delayed: 3.78 -0.17 (4.3%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.95 | 52 Week High | $ | |||
| Open | $3.95 | 52 Week Low | $ | |||
| Day High | $4.09 | P/E | N/A | |||
| Day Low | $3.64 | EPS | $ | |||
| Volume | 124,817 | |||||

